//./ActionParams/@language -> $page_language ->

Never miss a great news story!
Get instant notifications from Economic Times
AllowNot now


You can switch off notifications anytime using browser settings.
12,086.70114.9
Stock Analysis, IPO, Mutual Funds, Bonds & More

Divi's Laboratories Ltd.

ET 500

Rank 2018
306
ENGNew
  • ENG - English
  • HIN - हिन्दी
  • GUJ - ગુજરાતી
  • MAR - मराठी
  • BEN - বাংলা 
  • KAN - ಕನ್ನಡ 
  • ORI - ଓଡିଆ
  • TEL - తెలుగు
  • TAM - தமிழ்
  • NSE
    15:55 | 13-12-2019
  • BSE
    16:01 | 13-12-2019
1842.00

Today's Change

12.85 (0.70%)

Volume
AVERAGE VOLUME
5-Day
10-Day
30-Day

534,166

Open

1833.70

Prev. Close

1829.15

Day's Trend

  • Bid
  • Mkt Cap (₹ Cr.)
  • P/E (x)
  • P/B (x)
  • Div_ Yield (%)
  • BETA
    BETA
    1 Month
    3-Months
    6-Months
    1 Year
    3-Years
  • Offer
  • Face Value (₹)2.00
  • EPS-TTM (Rs.)49.37
  • BV/share (₹)262.07
  • 52Wk L/H1428.05/ 1847.95
  • Avg. Daily Volatility %
    Avg. Daily Volatility %
    1 Month
    3-Months
    6-Months
    1 Year
    3-Years
InsightsEvents| Recos| Updates| News| Speed

Divi's Laboratories Ltd Stock Price F & O Quotes

Buy Divi's Lab, target price Rs 1,800: Swati Hotkar| Recos
Buy
Buy Divi's Laboratories, target Rs 1,670: Sharekhan| Recos
Buy
Divi's Laboratories Ltd.Change Of Name Of The Share Transfer Agent Of The Company From KARVY FINTECH PRIVATE LIMITED To KFIN TECHNOLOGIES PRIVAT...| Announcement
Divi's Laboratories Ltd.Submission Of Half Yearly Disclosure On Related Party Transactions For The Half Year Ended 30 September, 2019| Announcement
Divi's Laboratories Ltd.Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation| Announcement
Divi's Laboratories Ltd.US-FDA Inspection Of Unit -I At Village Lingojigudem, Bhuvanagiri Yadadri District, Telangana| Announcement
Divi's Lab Q2 profit dips 12% to Rs 357 crore| News
Divi's Laboratories Ltd.Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Half Year Ended 30 September, 2019| Announcement
Divi's Laboratories Ltd.Board Meeting Intimation for Financial Results As Required Under Regulation 29 Of The SEBI (Listing Obligations And Disc...| Announcement
Divi's Laboratories Ltd.Announcement under Regulation 30 (LODR)-Newspaper Publication| Announcement
Divi's Laboratories Ltd.Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018| Announcement
Divi's Laboratories Ltd.Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate| Announcement
Divi's Laboratories Ltd.Compliance Certificate For Half Year Ended 30 September, 2019| Announcement
Divi's Laboratories Ltd.Shareholding for the Period Ended September 30, 2019| Announcement
Divi's Laboratories Ltd.Compliance Certificate For The Period Ended 30 September, 2019| Announcement
Divi's Laboratories Ltd.Statement Of Investor Complaints For The Quarter Ended September 2019| Announcement
Divi's Laboratories Ltd.Disclosure of Voting results of Postal Ballot (Regulation 44(3) of SEBI (LODR) Regulations, 2015)| Announcement
Divi's Laboratories Ltd.Declaration Of Postal Ballot Results| Announcement
Divi's Laboratories Ltd.Closure of Trading Window| Announcement
Divi's Laboratories Ltd.Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation| Announcement
Divi's Laboratories Ltd.Announcement under Regulation 30 (LODR)-Newspaper Publication| Announcement
Divi's Laboratories Ltd.Announcement under Regulation 30 (LODR)-Newspaper Publication| Announcement
Divi's Laboratories Ltd.Inspection Of Unit-II By EMA| Announcement
Divi's Laboratories Ltd. share price up by 0.70% from its previous close of Rs 1829.15. Divi's Laboratories Ltd. stock last traded price is 1842.00
Divi's Laboratories Ltd. Share Price
Value
Today/Current/Last
1842.00
Previous Day
1829.15
What's your view on Divi's Laboratories for the week?
Bearish
Bullish
View community Outlook >>

Be the first one to post on Divi's Laboratories Ltd.

Divi's Laboratories Ltd.
Quarterly Results

Figures in Rs. Cr
Sep 2019 
% Chg (Quarterly)
% Chg (Yearly)
Peer Range
Trend
Last 12 Quarters Trend
Sales
1,445.57
24.31
9.19
0.00
8123.35
Other Operating Income
0.00
0.00
0.00
0.00
174.16
Operating Profit
490.56
26.71
-5.93
-62.92
2640.87
Other Income
47.03
55.11
-41.53
-1.24
200.85
EBITDA
537.59
28.78
-10.69
-62.92
2640.87
Interest
3.79
1084.38
1479.17
0.00
116.00
Depreciation
45.93
4.79
8.30
0.00
473.28
Tax
131.09
29.96
-15.72
-320.70
266.03
Net Profit
356.78
30.96
-11.63
-127.07
1106.80
EPS (₹)
13.44
30.99
-11.64
-12.25
66.68

Divi's Laboratories Ltd Share Price

Vs Peers
Companies
LTP
Intraday
1W %
1M %
1 QTR %
1 YR %
3 YR %
5 Yr %
Trend -
D|M|Y
1842.00
0.70
3.26
10.13
13.12
21.02
21.02
21.02
449.35
0.13
0.82
3.57
-28.59
-40.13
-40.13
-40.13
261.00
-1.14
2.23
16.13
7.90
-25.30
-25.30
-25.30
461.25
0.04
1.27
2.98
-1.65
-12.48
-12.48
-12.48
756.25
1.00
-0.74
3.55
-1.03
-10.75
-10.75
-10.75
292.35
-0.17
1.16
13.89
25.66
-8.83
-8.83
-8.83
1865.60
0.43
0.76
5.25
8.39
4.48
4.48
4.48
2821.50
-2.90
-2.40
2.11
3.29
8.65
8.65
8.65
779.85
-1.66
-0.19
-4.25
-1.49
8.75
8.75
8.75
2075.60
-0.43
-0.18
0.47
12.83
9.31
9.31
9.31
301.60
0.92
-2.30
-8.59
-5.90
9.44
9.44
9.44
Top Loser for the period amongst the peers
Top Gainer for the period amongst the peers

Divi's Laboratories Ltd Risk Return Comparison

with peersNew

Divi's Laboratories Ltd
Financial Comparison

with peers
Management Efficiency
Divi's Laboratories Ltd 
peer Average
Peer Range
Trend
Return on Equity (%)
19.44
8.87
-99.01
47.57
Return on Assets (%)
22.20
5.79
-27.48
26.25
Return on capital Employed (%)
14.15
6.57
-130.86
23.01
Fixed Assets Turnover (x)
0.76
0.97
0.00
2.79
Profitability and Growth
Gross Profit Margin (%)
34.42
-8.77
-980.00
34.42
Operating Profit Margin(%)
37.84
0.38
-896.19
37.94
Net Profit margin (%)
27.34
2.06
-461.80
94.28
Financial Strength
Liquidity
Quick Ratio (x)
1.78
1.65
0.08
9.50
Current Ratio (x)
3.60
2.40
0.21
9.50
Cash ratio (x)
0.12
0.22
-0.52
1.40
Solvency
Debt Equity Ratio (x)
0.00
0.27
0.00
1.77
Coverage Ratios
Cash flows to long term debt (x)
0.07
3.76
0.00
45.52
Better performer than its peers on this ratioAverage performer than its peers on this ratioUnderperformer than its peers on this ratio

Divi's Laboratories Ltd Share Holding as on 30-06-2019

CategoryNo. of sharesPercentage
Promoters138,069,36052.01
ForeignInstitutions55,618,77320.95
NBanksMutualFunds38,723,27814.59
GeneralPublic20,760,5107.82
Others11,547,2834.35
FinancialInstitutions749,3760.28

MF Ownership Of Divi's Laboratories Ltd. Shares

Fund Name
Category
No. of shares
% Change in Shares (MOM basis)
% of AUM
Amount Invested (in ₹ Cr)
SBI Equity Hybrid Direct-G
Portfolio as on 30-11-2019
Hybrid: Aggressive Hybrid
5494031
9.43%
3.14%
981.34
SBI Bluechip Direct-G
Portfolio as on 30-11-2019
Equity: Large Cap
3611156
6.97%
2.75%
645.02
HDFC Mid-Cap Opportunities Direct-G
Portfolio as on 30-11-2019
Equity: Mid Cap
2138903
0.00%
1.68%
382.05
Nippon India Large Cap Direct-G
Portfolio as on 30-11-2019
Equity: Large Cap
2100000
-4.57%
2.88%
375.10
Axis Long Term Equity Direct-G
Portfolio as on 30-11-2019
Equity: ELSS
1924324
18.47%
1.62%
343.72

Liquid, Ultra Short Term funds and FMPs are not taken into account.

More Schemes

About Divi's Laboratories Ltd.

Divi's Laboratories Ltd., incorporated in the year 1990, is a Large Cap company (having a market cap of Rs 48844.89 Crore) operating in Pharmaceuticals sector.

Divi's Laboratories Ltd. key Products/Revenue Segments include Active Pharma Ingredients which contributed Rs 4727.84 Crore to Sales Value (96.88 % of Total Sales), Export Incentives which contributed Rs 116.91 Crore to Sales Value (2.39 % of Total Sales), Scrap which contributed Rs 25.53 Crore to Sales Value (0.52 % of Total Sales) and Contract Fees which contributed Rs 9.38 Crore to Sales Value (0.19 % of Total Sales)for the year ending 31-Mar-2019.

For the quarter ended 30-09-2019, the company has reported a Consolidated sales of Rs 1445.57 Crore, up 24.31 % from last quarter Sales of Rs 1162.88 Crore and up 9.19 % from last year same quarter Sales of Rs 1323.93 Crore Company has reported net profit after tax of Rs 356.78 Crore in latest quarter.

The company’s top management includes Dr.G Suresh Kumar, Dr.Murali K Divi, Dr.Ramesh B V Nimmagadda, Dr.S Ganapaty, Mr.K V K Seshavataram, Mr.Kiran S Divi, Mr.Madhusudana Rao Divi, Mr.N V Ramana, Mr.R Ranga Rao, Ms.Nilima Motaparti, Prof.Sunaina Singh. Company has Price Waterhouse Chartered Accountants LLP as its auditoRs As on 30-06-2019, the company has a total of 265,468,580 shares outstanding.

Close X
WatchlistPortfolio

Current Price>: 2389.88

Set Alert

Loading
Please wait...

Date Sources:Live BSE and NSE Quotes Service: TickerPlant | Corporate Data, F&O Data & Historical price volume data: Dion Global Solutions Ltd.
BSE Quotes and Sensex are real-time and licensed from the Bombay Stock Exchange. NSE Quotes and Nifty are also real time and licenced from National Stock Exchange. All times stamps are reflecting IST (Indian Standard Time).
By using this site, you agree to the Terms of Service and Privacy Policy.

Other useful Links


Copyright © 2019 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service

Loadingdata
More on:
Prices| Financials | Company Info | Reports | News | Competitors